Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 2/20 | 0.64 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | LTA4H | P09960 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.54 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4624885 | 0.98 | EBP (0.62) | EBPSIGMAR1CYP1A2LTA4HCYP2D6 | |
| SCHEMBL9706125 | 0.92 | EBP (0.72) | EBPSIGMAR1CYP1A2LTA4HCYP2D6 | |
| SCHEMBL12865043 | 0.90 | KDM4E (0.60) | EBPSIGMAR1CYP1A2LTA4HCYP2D6 | |
| SCHEMBL10509623 | 0.88 | EBP (0.55) | EBPSIGMAR1CYP1A2LTA4HCYP2D6 | |
| SCHEMBL11094544 | 0.87 | MAOB (0.57) | — | |
| Hydrochloric Acid SCHEMBL10572505 | 0.86 | EBP (0.51) | EBPSIGMAR1CYP1A2LTA4HCYP2D6 | |
| Hydrochloric Acid SCHEMBL9259688 | 0.86 | MAPT (0.51) | EBPSIGMAR1CYP1A2LTA4HCYP2D6 | |
| SCHEMBL11684281 | 0.84 | CYP1A2 (0.66) | CYP1A2LTA4HCYP2D6CYP2C9CYP2C19 | |
| SCHEMBL14570562 | 0.82 | KCNH2 (0.53) | EBPSIGMAR1CYP1A2LTA4HCYP2D6 | |
| SCHEMBL1985115 | 0.82 | EBP (0.62) | EBPSIGMAR1CYP1A2LTA4HCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112086450-B | Semiconductor device with a semiconductor layer having a plurality of semiconductor layers | 三星电子株式会社 | 2024-10-18 | — | — | CN | disclosed |
| CN-116155151-A | Alternating current generator and variable voltage regulating module thereof | 北京佩特来电器有限公司 | 2023-05-23 | — | — | CN | disclosed |
| US-11387229-B2 | Semiconductor device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-07-12 | — | — | US | disclosed |
| CN-216699881-U | Alternating-current generator and variable voltage adjusting module thereof | 北京佩特来电器有限公司 | 2022-06-07 | — | — | CN | disclosed |
| WO-2021003314-A1 | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | NUVATION BIO INC. (US) | 2021-01-07 | — | — | WO | disclosed |
| WO-2020210377-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | NUVATION BIO INC. (US) | 2020-10-15 | — | — | WO | disclosed |
| WO-2020210383-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | NUVATION BIO INC. (US) | 2020-10-15 | — | — | WO | disclosed |
| WO-2020070332-A1 | OXINDOLE COMPOUNDS FOR USE AS MAP4K1 INHIBITORS | ICHNOS SCIENCES S.A. (CH) | 2020-04-09 | — | — | WO | disclosed |
| EP-2975024-B1 | TETRACYCLIC COMPOUNDS | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2018-03-28 | — | — | EP | disclosed |
| US-RE46511-E1 | Fused pyrimidine derivatives for inhibition of tyrosine kinase activity | HANMI SCIENCE CO., LTD. (KR) | 2017-08-15 | — | — | US | disclosed |
| US-20070191447-A1 | Novel heterocyclic compound | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-08-16 | — | — | US | disclosed |
| US-7196080-B2 | Respiratory system disordeers; chronic obstructive pulminary disease | ASTELLAS PHARMA INC. (JP) | 2007-03-27 | — | — | US | disclosed |
| US-7183409-B2 | Basic mono- and bisazo compounds | CLARIANT FINANCE (BVI) LIMITED (VG) | 2007-02-27 | — | — | US | disclosed |
| US-7183409-B2 | Basic mono- and bisazo compounds | CLARIANT FINANCE (BVI) LIMITED (VG) | 2007-02-27 | — | — | US | disclosed |
| WO-2005063239-A9 | 3-(4-PIPERIDINE-1YLMETHYL-PHENYL)-PROPION ACID-PHENYLAMIDE-DERIVATIVES AND RELATED COMPOUNDS USED IN THE FORM OF MCH ANTAGONISTS (MELANINE CONCENTRATING HORMONE) FOR TREATING EATING DISORDERS | BOEHRINGER INGELHEIM INT (DE) | 2006-03-09 | — | — | WO | disclosed |
| WO-2005087761-A1 | NOVEL CYCLOALKYL-CONTAINING 5-ACYLINDOLINONES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL PRODUCTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-09-22 | — | — | WO | disclosed |
| EP-0109563-B1 | METHOD OF INCREASING BIOMASS IN PLANTS | US AGRICULTURE (US) | 1990-10-10 | — | — | EP | disclosed |
| US-4797153-A | PLANT GROWTH REGULATORS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1989-01-10 | — | — | US | disclosed |
| EP-0109563-A2 | Method of increasing biomass in plants | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1984-05-30 | — | — | EP | disclosed |
| WO-1984001489-A1 | METHOD OF INCREASING BIOMASS IN PLANTS | US AGRICULTURE (US) | 1984-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191447-A1 | Novel heterocyclic compound | OPRD1, GRIN3A, GRM3 | EBP 638/4885SIGMAR1 38/4885CYP1A2 256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.